(Press-News.org) The most common form of muscular dystrophy among adults is dystrophia myotonica type 1 (DM1), where approximately 1 in every 8000 is affected by the disease. The severity of the disease varies from mild forms to severe congenital forms. It is dominantly inherited and accumulates through generations, gaining increased severity and lowered age of onset. DM1 is characterised by accumulating toxic aggregates of ribonucleic acids (RNA) from a specific mutated gene (see figure 1).
When this RNA, which contains thousands of CUG nucleotide repeats, builds up in the cell, it attracts several cellular proteins, including muscleblind 1 (MBNL1) (see figure 2, left). This binding inhibits the normal function of MBNL1, which means that the cellular level of a number of specific proteins becomes deregulated and the disease develops.
Enzyme characterisation in muscular dystrophy patients
The researchers work at the Department of Molecular Biology and Genetics and the Department of Biomedicine, Aarhus University, where they characterised an enzyme called DDX6, found in both normal cells and cells from muscular dystrophy patients.
The enzyme constantly tries to disperse the toxic aggregates and release MBNL1 in cells from muscular dystrophy patients, which means that the protein can carry out its normal function (see figure 2, right). The enzyme is found in many different cell types, where it performs a number of vital functions. The researchers showed that an artificial increase in the level of DDX6 in muscular dystrophy cells reduces the number of RNA aggregates, while more are formed when DDX6 is removed from the cells.
DDX6 belongs to a class of enzymes called helicases, which can change RNA structure and also regulate the ability of proteins to bind RNA. By purifying DDX6 from human cells, the researchers succeeded in getting the enzyme to bind and carry out an enzymatic reaction outside the cell, thus changing the structure of the toxic RNA.
These results indicate that DDX6 has a direct impact on toxic RNA aggregation in cells from muscular dystrophy patients in addition to its normal functions.
It remains unlikely that DDX6 can be used directly in the treatment of muscular dystrophy, since the enzyme carries out a number of important processes in the cell, which could potentially become deregulated leading to other diseases. However, the results provide important insights into the basic mechanisms of the disease, and natural differences in enzyme levels in different types of cells (or individuals) could possibly explain observed tissue-specific differences in the development of the disease.
INFORMATION:
The research team consists of Olof Pettersson, Lars Aagaard and Thomas G. Jensen, Department of Biomedicine, and Rune Thomsen, Diana Andrejeva (presently at University of Copenhagen) and Christian Kroun Damgaard, Department of Molecular Biology and Genetics, Aarhus University.
Link to the scientific article in the international journal Nucleic Acids Research: DDX6 regulates sequestered nuclear CUG-expanded DMPK-mRNA in dystrophia myotonica type 1: http://nar.oxfordjournals.org/content/early/2014/05/03/nar.gku352.full
New knowledge about muscular dystrophy
2014-05-05
ELSE PRESS RELEASES FROM THIS DATE:
Genetic diagnosis can rule out a suspected Huntington's chorea patient
2014-05-05
Huntington's disease is an autosomal-dominant inherited neurodegenerative disease with a distinct phenotype, but the pathogenesis is unclear. Although patients with a family history have more typical clinical symptoms, signs, and pathological changes, as well as an unambiguous clinical diagnosis, other diseases with dance-like movements, e.g., dentatorubral-pallidoluy-sian atrophy, spinocerebellar ataxia type 17, Huntington's disease-like-2, and neuroferritinopathy, are difficult to identify and distinguish from Huntington's disease. By mutation screening for CAG repeats ...
Animal hoarding, a lesser-known problem for public health and welfare
2014-05-05
Animal hoarding is a psychiatric disorder that consists of accumulating large numbers of animals at home, usually cats and dogs, without providing them with a minimal standard of care. Researchers from IMIM (Hospital del Mar Research Institute) publish the first European study to provide data on this disorder, in the Journal Animal Welfare. The disorder is still largely unknown and has a negative effect on the health of both the people who suffer from it and the animals involved.
"This is the first step towards public recognition of this disorder, a disorder that constitutes ...
Nanoengineers develop basis for electronics that stretch at the molecular level
2014-05-05
Nanoengineers at the University of California, San Diego are asking what might be possible if semiconductor materials were flexible and stretchable without sacrificing electronic function?
Today's flexible electronics are already enabling a new generation of wearable sensors and other mobile electronic devices. But these flexible electronics, in which very thin semiconductor materials are applied to a thin, flexible substrate in wavy patterns and then applied to a deformable surface such as skin or fabric, are still built around hard composite materials that limit their ...
Minneapolis Heart Institute Foundation implants its 1st world's smallest cardiac pacemaker
2014-05-05
MINNEAPOLIS, MN – May 1, 2014 – The Minneapolis Heart Institute Foundation (MHIF) announced today the first implant of the world's smallest pacemaker at the Minneapolis Heart Institute. The device was implanted as part of a global clinical trial and the procedure was the first of its kind in the Midwest.
One-tenth the size of a conventional pacemaker, and comparable in size to a large vitamin, the Medtronic Micra™ Transcatheter Pacing System is delivered directly into the heart through a catheter inserted in the femoral vein. Once positioned, the pacemaker is securely ...
Penn study shows stimulant drug may help women cope with post-menopausal memory lapses
2014-05-05
NEW YORK – Menopausal women have long reported experiencing hot flashes, mood swings, night sweats and memory lapses, too.
A new study from researchers in the Perelman School of Medicine at the University of Pennsylvania shows preliminary evidence that the psychostimulant drug lisdexamfetamine (LDX) can aid post-menopausal women by improving attention and concentration, organization, working memory and recall. The findings will be presented by C. Neil Epperson, MD, director of the Penn Center for Women's Behavioral Wellness, on Tuesday during the American Psychiatric ...
Inbred wolves struggle, moose proliferate at Isle Royale National Park
2014-05-05
During their annual Winter Study at Isle Royale National Park, scientists from Michigan Technological University counted nine wolves organized into one breeding pack and a second small group that is a remnant of a formerly breeding pack.
In the Isle Royale Wolf-Moose Study’s annual report released today, the researchers say that over the past three years, they have tallied the lowest numbers of wolves ever: nine in 2011–12, eight in 2012–13 and nine in 2013–14. During the same period, predation rates—the proportion of the moose population killed by wolves—also dropped ...
Infusion of young blood recharges brains of old mice, Stanford study finds
2014-05-05
STANFORD, Calif. — Something — or some things — in the blood of young mice has the ability to restore mental capabilities in old mice, a new study by Stanford University School of Medicine investigators has found.
If the same goes for humans, it could spell a new paradigm for recharging our aging brains, and it might mean new therapeutic approaches for treating dementias such as Alzheimer's disease.
In the study, to be published online May 4 in Nature Medicine, the researchers used sophisticated techniques to pin down numerous important molecular, neuroanatomical and ...
Compound Formula Rehmannia alleviates dyskinesia in Parkinson's disease
2014-05-05
Levodopa is the preferred treatment for Parkinson's disease in the clinic. However, long-term use of levodopa may lead to various motor complications, among which levodopa-induced dyskinesia is the most common, severely affecting patients' quality of life. Dr. Jiancheng He and co-workers from Shanghai University of Traditional Chinese Medicine in China established a model of Parkinson's disease dyskinesia in rats, and treated these animals with Compound Formula Rehmannia. They found that Compound Formula Rehmannia alleviates levodopa-induced dyskinesia in Parkinson's disease ...
New idea for hearing improvement in patients with hearing aids under background noise
2014-05-05
Patients with implanted artificial cochlea often complain that they cannot recognize speech well in natural environments, especially if background of noise is present. Researchers think that a poor ability to localize sound in a complex auditory environment is responsible for the weak speech perception observed under these conditions. Pentobarbital anesthesia prolongs the recovery time of responses to lagging stimulus. The effects of pentobarbital anesthesia on the precedence effect stem from decreased dissociation of gamma-aminobutyric acid from its receptor (i.e., it ...
When highest perceptual ability occurs in a day?
2014-05-05
Many previous chronobiological studies have reported on detection of circadian fluctuation in performing simple motor tasks, fine skilled movement, and anaerobic exercise. However, to the best of our knowledge, literature concerning variation of sensory function according to the circadian cycle is lacking. Therefore, Yong Hyun Kwon and co-workers from Yeungnam University College of Science and Technology in Republic of Korea observed and compared the circadian fluctuations in tactile sense, joint reposition sense and two-point discrimination in 21healthy adult subjects ...